Area of interest- Proteomics and signalling pathways
Joined October 2010
- Tweets3.2K
- Following3.6K
- Followers585
- Likes5.8K
Dr. Rex Devasahayam Arokia Balaya, MPhil., Ph.D. retweeted
What mattered, I realized, was not to be some imaginary perfect mentor with all the answers, but to get to know my mentee, including her hopes and ambitions, and offer whatever guidance and support I could based on my own experiences. @ScienceMagazine #TIC2026 #phd #Academic
Dr. Rex Devasahayam Arokia Balaya, MPhil., Ph.D. retweeted
“If we can predict the [protein's] shape, we can design a drug that recognizes the harmful form and leaves the healthy one alone.”
A Hopkins-led team backed by up to $52M from @ARPA_H will build an AI model to decode how proteins misfold in Parkinson’s, cancer, and other diseases. bit.ly/4zMyCdb
Dr. Rex Devasahayam Arokia Balaya, MPhil., Ph.D. retweeted
New online! Small variant calling in the era of long-read sequencing dlvr.it/TW0GMJ
Dr. Rex Devasahayam Arokia Balaya, MPhil., Ph.D. retweeted
KEGG for characterizing genomes and pathways in the biosphere academic.oup.com/nar/advance…
Dr. Rex Devasahayam Arokia Balaya, MPhil., Ph.D. retweeted
🧬 Think of your genes like a family recipe—passed down from your parents with instructions that help shape how your body works. Over time, changes can occur in those instructions. Some may have little effect, while others can increase the risk of disease.
NIH researchers are studying why additional genetic changes in some people born with a mutated gene called RUNX1 can increase their risk of developing blood cancer, while others with the mutation may never develop cancer.
🎥 Watch to learn more: bit.ly/4jCYALo
Dr. Rex Devasahayam Arokia Balaya, MPhil., Ph.D. retweeted
RAStoERK: A reference interaction atlas for insights into signaling and disease dlvr.it/TW4mSm
Dr. Rex Devasahayam Arokia Balaya, MPhil., Ph.D. retweeted
Recent patents relating to systems, methods and compositions for use in genome editing nature.com/articles/s41587-0…
rdcu.be/qoVixcVcNrAa
Dr. Rex Devasahayam Arokia Balaya, MPhil., Ph.D. retweeted
We're unable to measure our immune system status in the clinic. But that is about to change.
Our @nature piece today, w/ @HugoAerts @nbirkbak @TsangLab
nature.com/articles/d41586-0…
Dr. Rex Devasahayam Arokia Balaya, MPhil., Ph.D. retweeted
Cells from your mother can take up residency in your brain – what are they doing there? Columnist Helen Thomson explores how microchimerism can influence brain development and health even in later life.
Dr. Rex Devasahayam Arokia Balaya, MPhil., Ph.D. retweeted
α‐Synuclein pathology drives region‐specific tau deposition alz-journals.onlinelibrary.w…
Dr. Rex Devasahayam Arokia Balaya, MPhil., Ph.D. retweeted
Nature research paper: WEE1 opposes APC/CCDH1 activity to promote S phase entry
go.nature.com/4hYLKG7
Dr. Rex Devasahayam Arokia Balaya, MPhil., Ph.D. retweeted
I captured this video in my lab to show the power of medicines called T-cell engagers.
Left: T cells move in and out of a cancer tumoroid, largely ignoring it.
Right: Add a T-cell engager, and the T cells attack. Once they recognize their targets, they tear through the tumor.
Dr. Rex Devasahayam Arokia Balaya, MPhil., Ph.D. retweeted
Did you make an #OpenScience tool using Brain Map? Submit it to our community tools page!
Tools should use Brain Map resources, extend the use of data, provide new ways to access and analyze data, or support educational use.
Learn more and submit:
bit.ly/4zTIYb9
Dr. Rex Devasahayam Arokia Balaya, MPhil., Ph.D. retweeted
Rational Tuning of Intracellular Release Kinetics
in PROTAC–Peptide Conjugates via Positional Modulation of Functional
Peptide Domains pubs.acs.org/abmcb8/article/…
Dr. Rex Devasahayam Arokia Balaya, MPhil., Ph.D. retweeted
Colorectal cancers with distinct metastatic potential trigger divergent early T cell responses @JExpMed
@RockefellerUniv
rupress.org/jem/article-abst…
Dr. Rex Devasahayam Arokia Balaya, MPhil., Ph.D. retweeted
We are excited to announce that the Consortium for Top-Down Proteomics is relaunched as The Proteoform Alliance. Thanks to our community for building to this inflection point. Details at proteoforms.org or press release globenewswire.com/news-relea…
Dr. Rex Devasahayam Arokia Balaya, MPhil., Ph.D. retweeted
Last call: Apply for the BioInnovation Institute & Science Prize for Innovation
This prize recognizes bold researchers who are asking fundamental questions at the intersection of the life sciences and entrepreneurship.
The Grand Prize winner will receive a cash prize of USD 25,000 and have their winning essay published in Science, in print and online.
Apply by 1 November 2026: bit.ly/3TuI19S
ALT The image features a logo with the words "BII Science Prize for Innovation" written in dark lettering.
Dr. Rex Devasahayam Arokia Balaya, MPhil., Ph.D. retweeted
Single-cell multi-omics reveals archetypal regulatory programs shared across T cell subsets @CellReports
cell.com/cell-reports/fullte… @YuriPritykin @Princeton
Dr. Rex Devasahayam Arokia Balaya, MPhil., Ph.D. retweeted
🧠 You’ve probably heard of Alzheimer’s disease. But what about Lewy body dementia (LBD)? LBD is the second most common form of dementia, and it can affect thinking, movement, sleep, and mood.
Download or order a free booklet about LBD to learn more: bit.ly/4kg9OWi.
ALT A group of three people standing together, smiling, with one holding a clipboard. The text reads, "October is Lewy Body Dementia Awareness Month." A button below states, "Learn more about NIH resources." Logos for the U.S. Department of Health and Human Services and NIH are at the bottom.
Dr. Rex Devasahayam Arokia Balaya, MPhil., Ph.D. retweeted
Tiny models. Big research potential.
Organoids are small, lab-grown models that mimic how human organs work, helping scientists better understand disease and explore new treatments. Learn how the NIH Standardized Organoid Modeling (SOM) Center is working to make these powerful research tools more reliable and accessible.
Explore the SOM Center: nih.gov/som.